Skip to main content
US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
Screen a stock
TERMINAL
SU

SUPNStock

Nasdaq Global Market · Healthcare · US

$28.61 last close 2026-11-20
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment SUPN's does — no target price to set, unlike a price alert.

Stable Ratio screen, 4 of 7 decided standards passing. No standard's deciding ratio sits within 3 points of its line. What would change it

Sharia status
COMPLIANT
Per our in-house ratio engine
4 of 7 pass our financial screen — the standards disagree
Purification 1.74% *HTR non-permissible income 1.78%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
🟠 NOT YET
The main driver: lagging the market by 25.4%. More negatives than positives right now. The setup isn't ready — check...
Scores: 1 bullish / 2 bearish
63
of 100
Setup confidence — system conviction, not win probabilityC

Trade plan

Posted with a stop, a target and the level that invalidates it. It resolves into the public record either way.

EMA_PULL · SCALP
Entry
$30.70
Stop
$30.39
Target
$31.32
Risk : Reward 2.0R

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure0 of 5 timeframes bullish · 56.5% aligned
VWAPPrice below VWAP ($28.90)
VolumeRelative volume 3.7× the 20-day average
Momentum10-day rate of change +11.0%
Overall readNOT YET

SUPN is currently considered halal (Sharia-compliant), per our in-house ratio engine. See the full ratio breakdown and business-activity screen below for the reasoning.

This sits among 434 compliant Healthcare stocks we track. See compliant Healthcare stocks →

Market & analysts
Price target
$54.12
+89.2% · 8 analysts
Institutional own.
61.6%
of shares
Momentum (10d)
+11.0%
rate of change
SMC grade
C · 63
56.5% aligned
1.74% *
Purification ratio (secondary provider, uncertain)
1.78%
Non-permissible income — HTR, from filings (2025-12-31)
C · 63
SMC grade — 56.5% timeframe alignment
+11.0%
Rate of change (10d)
$54.12
Price target (+89.2%) · 8 analysts
61.6%
Institutional ownership

How the status reached this point

Compliant · status tracked since Nov 17, 2026

No change to SUPN’s published status has been recorded since our daily status check began on Nov 17, 2026. What it read before then is not on record here.

Read once a day from the status this page publishes, last on Nov 21, 2026. The per-methodology record is under “What changed, and when” in the in-house research.

Free email, sent when our compliance re-scan finds a change.

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-09-30. These ratios come from the issuer's own published statements rather than structured SEC data.

AAOIFI divides by the market cap: $6.0B as of 2026-11-18. At the 2026-11-20 close it is about $6.0B (the stored market cap moved by the share price since, not a new share count), and at that cap AAOIFI's interest-bearing debt ratio would read 8.3% (8.3% at the stored cap, against a 30% line) and interest-bearing investments ratio would read 5.1% (5.1% at the stored cap, against a 30% line). The published verdict changes only when the company is re-screened.

Business activity: cleared (no excluded categories detected)

AAOIFI Pass 3 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 8.31% 30.00% Pass(21.7pp buffer)
Interest-bearing investments 5.06% 30.00% Pass(24.9pp buffer)
Non-permissible income 1.78% 5.00% Pass(3.2pp buffer)
Usmani Fail 4 of 5 ratios pass
RatioValueThresholdResult
Interest-bearing debt 37.61% 33.00% Fail(4.6pp over)
Interest-bearing investments 22.90% 33.00% Pass(10.1pp buffer)
Non-liquid assets 56.61% at least 20.00% Pass(36.6pp above the floor)
Non-permissible income 1.78% 5.00% Pass(3.2pp buffer)
Net liquid assets per share $-723.0M under mkt cap $6.0B Pass
MSCI Fail 2 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 37.61% 33.33% Fail(4.3pp over)
Cash + interest-bearing securities 22.90% 33.33% Pass(10.4pp buffer)
Accounts receivable 43.39% 33.33% Fail(10.1pp over)
Non-permissible income 1.78% 5.00% Pass(3.2pp buffer)
FTSE Fail 3 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 36.64% 33.33% Fail(3.3pp over)
Cash + interest-bearing securities 22.90% 33.33% Pass(10.4pp buffer)
Accounts receivable 43.39% 50.00% Pass(6.6pp buffer)
Non-permissible income 1.78% 5.00% Pass(3.2pp buffer)
Dow Jones Islamic Market Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 12.03% 33.00% Pass(21.0pp buffer)
Cash + interest-bearing securities 7.32% 33.00% Pass(25.7pp buffer)
Accounts receivable 6.55% 33.00% Pass(26.4pp buffer)
Non-permissible income 1.78% 5.00% Pass(3.2pp buffer)
S&P Shariah Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 14.05% 33.00% Pass(18.9pp buffer)
Cash + interest-bearing securities 8.56% 49.00% Pass(40.4pp buffer)
Accounts receivable 7.66% 49.00% Pass(41.3pp buffer)
Non-permissible income 1.78% 5.00% Pass(3.2pp buffer)
MSCI M-Series Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 14.05% 33.33% Pass(19.3pp buffer)
Cash + interest-bearing securities 8.56% 33.33% Pass(24.8pp buffer)
Accounts receivable 16.21% 49.00% Pass(32.8pp buffer)
Non-permissible income 1.78% 5.00% Pass(3.2pp buffer)

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

AAOIFI Standard 21 (% of market cap)non permissible income ratio 3.2pts
Usmani (% of total assets)non permissible income ratio 3.2pts
Dow Jones Islamic Market (% of 24-mo avg market cap)non permissible income ratio 3.2pts
MSCI Islamic Index (% of total assets)receivables ratio 10.1pts
Usmani (% of total assets)debt ratio 4.6pts
MSCI Islamic Index (% of total assets)debt ratio 4.3pts

The numbers the ratios are built from

Read from SUPN's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $1.2B 2025-12-31 RevenueFromContractWithCustomerExcludingAssessedTax
Interest-bearing debtShort and long-term borrowings $488.0M 2026-09-30 LongTermDebtNoncurrent, LongTermDebtCurrent
Cash and interest-bearing securitiesCash, equivalents and marketable securities $305.0M 2026-09-30 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
Total assetsBalance sheet total $1.3B 2026-09-30 Assets
Market capDenominator for AAOIFI $6.0B live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $2.2B 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $2.5B 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $22.0M 2025-12-31 InvestmentIncomeInterest

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

Sources

Filing information. Balance sheet: Quarterly report (10-Q) filed 2026-10-29, period ended 2026-09-30. Income statement: Annual report (10-K) filed 2026-02-26, period ended 2025-12-31. Screened 2026-11-18.

  • Total assets$1.3B
    Assets · period ended 2026-09-30 · 10-Q filed 2026-10-29
  • Interest-bearing debt$488.0M
    LongTermDebtNoncurrent $0 · period ended 2026-09-30 · 10-Q filed 2026-10-29
    LongTermDebtCurrent $488.0M · period ended 2026-09-30 · 10-Q filed 2026-10-29
  • Cash and interest-bearing securities$305.0M
    CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · period ended 2026-09-30 · 10-Q filed 2026-10-29
  • Receivables$273.0M
    AccountsReceivableNetCurrent · period ended 2026-09-30 · 10-Q filed 2026-10-29
  • Revenue$1.2B
    RevenueFromContractWithCustomerExcludingAssessedTax · period ended 2025-12-31 · 10-K filed 2026-02-26
  • Interest income (non-permissible)$22.0M
    InvestmentIncomeInterest · period ended 2025-12-31 · 10-K filed 2026-02-26
  • Market cap$6.0B
    Market quote passed in by the screen (Finnhub company profile; Yahoo Finance where Finnhub has none), 2026-11-18 · not a filing figure, so no link

7 reported values cited from 2 SEC filings, read from SEC's XBRL company facts when this symbol was screened. A link opens the filing's index on EDGAR.

What changed, and when

Verdict history for SUPN. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-11-18 Pass → Fail filing re-screen

Tracked since 2026-09-07.

What would change the status

The headline verdict is the majority of the decided ratio standards — 4 pass and 3 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-09-30; market cap as stored on 2026-11-18.

No standard's deciding ratio sits within 3 points of its line.

The ratios that move with the share price

AAOIFI's debt ratio (8.3% against a 30% line) would only fail if the market cap fell by 72%, to $1.7B. At the 2026-11-20 close it would read 8.3%.

AAOIFI's investments ratio (5.1% against a 30% line) would only fail if the market cap fell by 83%, to $1.0B. At the 2026-11-20 close it would read 5.1%.

Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.

Shariah-compliant alternatives

Compliant companies in Drug Manufacturers - Specialty & Generic listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.

CompanyMarket capPrice, day
GALDYGalderma Group AG - ADR $47.7B —
HLNHaleon plc - ADR $44.4B —
NBIXNeurocrine Biosciences, Inc. $15.9B —
RDYDr. Reddy`s Laboratories Ltd. - ADR $10.1B —
ALKSAlkermes plc $7.9B —

A dash means no fresh quote is cached for that symbol; this list does not fetch one.

32.4629.9227.3924.8622.332025-11-242026-05-272026-11-20

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
26.94
S2
27.63
S1
27.99
PIVOT
28.68
R1
29.04
R2
29.73
R3
30.09

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
39.27 – 46.05
±7.94% from 42.66, made 2026-09-27 · resolves 2026-10-04
STRONG SELL
from 19 indicators
78.6% of our last 30385 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 53.9% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG BUY
19 indicators
OscillatorsSTRONG BUY
3 buy · 4 neutral · 0 sell
Moving averagesSTRONG BUY
10 buy · 0 neutral · 2 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)53.90NEUTRAL
Stochastic %K (14)47.19NEUTRAL
CCI (20)46.57NEUTRAL
Williams %R (14)-52.81NEUTRAL
MACD (12,26,9)0.06BUY
ROC (10)9.37BUY
Momentum (10)2.45BUY
EMA (10)28.60BUY
SMA (10)28.85SELL
EMA (20)28.25BUY
SMA (20)28.07BUY
EMA (30)28.06BUY
SMA (30)27.64BUY
EMA (50)28.01BUY
SMA (50)27.64BUY
EMA (100)28.15BUY
SMA (100)28.67SELL
EMA (200)27.67BUY
SMA (200)27.82BUY

About SUPN

Healthcare · Drug Manufacturers - Specialty & Generic

Supernus, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; and SUBOXONE Film, a buprenorphine and naloxone sublingual film. It also manufactures SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). In addition, the company is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Supernus, Inc. was formerly known as Indivior Pharmaceuticals, Inc. and changed its name Supernus, Inc. in November 2026. Supernus, Inc. was incorporated in 2014 and is headquartered in Rockville, Maryland.

supernus.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Latest Signal — 2026-11-03

EMA PULL
Type · SCALP
30.70
Entry
30.39
Stop
31.32
Target
LOSS
Outcome · exit 30.39 (-1.01%)

Stop 30.39 Now 28.61 Target 31.32

Verdict

🟠 NOT YET

The main driver: lagging the market by 25.4%. More negatives than positives right now. The setup isn't ready — check back when the trend or RSI changes.

Scores: 1 bullish / 2 bearish

Grade verdict

Average — needs more confirmation before sizing up

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BEARISH 63
⏰ 4H RANGING 36
🕐 1H RANGING 98
⏱ 15-Min BEARISH 130
⏲ 5-Min BEARISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

+11.0%
Rate of change (10d)
3.7×
Volume vs its 20-day average
-3.09
MACD (BULLISH)

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-17 · Asset managers net 895049 (-19081)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.